News & Events


    art photonics GmbH was co-sponsor of EPIC Technology Workshop “Unmet Health Care Needs as opportunities for Photonics Technologies”


    Optimizing the Road to Clinical Products
    27-28 November 2013
    Maastricht, The Netherlands (hosted by Maastricht University Medical Center)

    Session 1 “Setting the Scene – Introductory Presentations”

    • The technology and business landscape
    • Developing new ways to fund biophotonics devices
    • The regulatory environment for medical devices

    Session 2 “Electronics & Optics for Point-of-Care Devices for Chronic and Infectious Diseases”
    Used to solve scientific issues, Biophotonics business environment is yet structured around a few key players plus hundreds of SMEs and start-ups for early validation of Biophotonics solutions. Deployment of such solutions within Health Care and Food markets may be hard without support from major industrial players with enough market share and financial means to meet costly regulatory issues. Which parties will be the most suited to solve industrial problems linked to mass-market Biophotonics chip integration? A first move from high end products to desktop devices was performed by Analytics companies. Governments and Health Insurers increasingly endeavour to stimulate more self-care. The main question is: “Who will put the next Biophotonics devices in our kitchens, bedrooms, bathrooms and pockets?”

    Session 3 “Photonics Components for Medical Imaging & Microscopy”
    Optical Imaging provides relevant diagnostic information either through the analysis of endogenous fluorescence or through the tracking of exogenous fluorescent molecular probes. It is contributing strongly to preclinical research because it is a non-invasive and non-ionizing method that works in real time at variable spatial range (nm to mm) and temporal resolutions (µsec to minutes), with high sensitivity (femtomolar to picomolar), from whole-body to subcellular scales in small animal studies.

    The passage of Optical Imaging from the animal studies stage into the clinic is now linked to the availability of injectable tracers, and also suffers from limitations like an insufficient depth of investigation, need for improved 3D resolution and a poor linearity of the measures. Different modalities for Imaging are still looking for the relevant components to reach medical standards, like among others:

    • Diffuse spectral optical imaging to provide information such as total hemoglobin concentration, blood oxygen saturation, water and lipid concentration without the injection of an exogenous contrast agent,
    • Auto-fluorescence, as well as molecular imaging by targeted fluorescent markers to detect, localize and quantify tissues of interest,
    • Photo-acoustic imaging to get a high resolution reconstruction of optically contrasted structures in deep tissues. Integration of Cellular microscopy techniques (confocal, spectroscopy, Raman, etc.) into endoscopic instruments to allow intra-vital in vivo microscopy to improve and/or accelerate the diagnosis of several pathologies in the clinic.

    Session 4 “Unmet Health Care Needs as opportunities for Photonics Technologies”
    Short company/technology presentations by members of EPIC.